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Abstract
There is an increasing amount of clinical evidence that hypomagnesemia (serum Mg2+ lev-
els < 0.7 mmol/l) contributes to type 2 diabetes mellitus pathogenesis. Amongst other
hypotheses, it has been suggested that Mg2+ deficiency affects insulin secretion. The aim of
this study was, therefore, to investigate the acute effects of extracellular Mg2+ on glucose-
stimulated insulin secretion in primary mouse islets of Langerhans and the rat insulinoma
INS-1 cell line. Here we show that acute lowering of extracellular Mg2+ concentrations from
1.0 mM to 0.5 mM did not affect glucose-stimulated insulin secretion in islets or in insulin-
secreting INS-1 cells. The expression of key genes in the insulin secretory pathway (e.g.
Gck, Abcc8) was also unchanged in both experimental models. Knockdown of the most
abundant Mg2+ channel Trpm7 by siRNAs in INS-1 cells resulted in a 3-fold increase in insu-
lin secretion at stimulatory glucose conditions compared to mock-transfected cells. Our data
suggest that insulin secretion is not affected by acute lowering of extracellular Mg2+
concentrations.
Introduction
Globally, the number of people that suffer from type-2 diabetes mellitus (T2DM) is steadily
increasing, and the prevalence is predicted to pass the threshold of 500 million people by 2030
[1]. T2DM is characterized by impaired insulin secretion (i.e. insulin deficiency) and insulin
sensitivity (i.e. insulin resistance), explaining the underlying pathophysiological mechanism
for hyperglycemia (fasting serum blood glucose > 7 mmol/L) [2].
There is increasing evidence that hypomagnesemia (blood magnesium (Mg2+)< 0.7 mmol/
L) is associated with T2DM pathogenesis and related complications [3]. Several epidemiologi-
cal studies have shown that hypomagnesemia is higher in T2DM patients (14% - 48%) than in
controls (2.5% - 15%) [3]. Indeed, a patient cohort of almost 400 T2DM patients showed that
30.6% suffered from hypomagnesemia with plasma Mg2+ levels below 0.7 mmol/L [4]. Fur-
thermore, Mg2+ supplementation in T2DM patients improved insulin sensitivity and glucose
metabolism [5–7].
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Small scale clinical studies have demonstrated that insulin secretion may be lower in T2DM
patients with hypomagnesemia [8, 9]. Supplementation of individuals without diabetes with
MgCl2 significantly increased beta-cell function in a small randomized clinical trial [10]. How-
ever, experimental data concerning the role of Mg2+ in insulin secretion are conflicting, as
both inhibitory and stimulatory effects have been reported in rodent models of hypomagnese-
mia. Isolated islets of rats on a Mg2+-deficient diet for 11 weeks showed a higher basal and glu-
cose-stimulated insulin response [11]. In contrast, Legrand et al observed a reduced insulin
response to glucose in rats on a Mg2+-deficient diet for 6 weeks compared to controls [12].
Interpretation of these contradictory results are further complicated since both short-term and
long-term effects of Mg2+ may play a role.
In this study, we aimed to delineate the acute effects of extracellular Mg2+ concentrations
on glucose-stimulated insulin secretion in isolated primary mouse islets of Langerhans and
INS-1 cells under physiological and hyperglycemic conditions.
Materials and methods
Animal care
All procedures were conducted in compliance with the UK Animals Scientific Procedures Act
(1986) and approved by the University of Oxford, Department of Physiology, Anatomy and
Genetics Ethics Committee. Mice were housed in same-sex littermate groups of 2–8 animals,
in a temperature and humidity-controlled room on a 12 hr light-dark cycle (lights on 7 am).
Water and food (Special Diet Services, RM3) were available ad libitum. We used 10- to
16-week-old mice with a mixed (C3H, C57BL/6N, 129/sv) genetic background, as previously
described [13]. Littermates consisting of wild-type mice, mice carrying Cre recombinase
under the control of the rat insulin promoter (RIPII-Cre-ER mice), and mice carrying a trans-
gene consisting of a floxed STOP codon upstream of a Kir6.2-V59M gene that was inserted
into the ROSA locus (ROSA mice) (14), were used for insulin secretion experiments. The
floxed Kir6.2 gene is not expressed due to the presence of the STOP codon. Likewise Cre-
recombinase is not expressed as the gene is only activated when mice are injected with tamoxi-
fen. We did not observe any differences in insulin secretion between these mice [14], or
between these mice and wild-type mice on a pure C57bl/6N background.
Pancreatic islet isolation
Mice were sacrificed by cervical dislocation, and pancreatic islets were isolated by collagenase
digestion. In brief, the distal end of the common bile duct was tied near the anatomical transi-
tion to the duodenum, and the pancreas was distended by injecting HANKS (in mM: 137
NaCl, 2.5 CaCl2, 1.0 NaH2PO4, 5.6 KCl, 4.2 NaHCO3, 2.5 MgSO4 and 10 HEPES (pH 7.4 with
NaOH)) containing Liberase (Roche, Mannheim, Germany) (0.33 mg/ml) into the common
bile duct. After digestion at 37˚C for 16 min, islets were washed in the same buffer, supple-
mented with 0.2% Bovine Serum Albumin (BSA) (Sigma, St. Louis, USA) and 0.05% D-glucose
(Fisher Scientific, Leicestershire, UK). Islets were handpicked using a dissecting microscope
into RPMI 1640 medium (Gibco, Darmstadt, Germany) containing 10% FBS (Gibco, Paisley,
Scotland), 1% Penicillin-Streptomycin (Gibco, Paisley, Scotland) and 11 mM D-Glucose. They
were either left for 24 hrs in this medium at 37˚C in a humidified atmosphere with 5% CO2, or
(as indicated) cultured for 24 hrs in home-made RPMI (S1 Table) with either normal (1.0
mM) or low (0.1 mM) extracellular magnesium. Islets from different mice were pooled in all
experiments.
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Islet static insulin secretion
Groups of size-matched islets were handpicked and washed in Krebs-Ringer-bicarbonate
(KRB) buffer: (in mM: 118.5 NaCl, 2.5 CaCl2, 1.2 KH2PO4, 4.7 KCl, 25 NaHCO3,1.2 MgCl2
and 10 HEPES (pH 7.4 with NaOH)), followed by a 0.5 hr pre-incubation in KRB without glu-
cose (non-stimulant condition) at 37˚C, 5% CO2 infusion. Static insulin secretion was assessed
by challenging the islets with final concentrations of glucose and MgCl2 as indicated for 1 hr at
37˚C, 5% CO2 infusion. The supernatant was collected to measure insulin secretion using a
mouse insulin ELISA (Mercodia, Uppsala, Sweden). Islets were lysed in RIPA buffer (65 mM
Tris-HCL, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS, and
10% glycerol (pH 7.4 with HCl)) for 15 min on ice to extract total insulin content.
Quantitative real time PCR
Islets were lysed directly after isolation or after culture for 24 hrs in home-made RPMI (S1
Table) with glucose and MgCl2, as indicated. Islets were lysed by Qiazol (Qiagen, Hilden, Ger-
many) using the TissueLyser II, and chloroform (Sigma, St. Louis, USA) phase separation was
used to extract total RNA. Purification was performed according to the manufacturer’s proto-
col, including an on-column DNase (Qiagen, Hilden, Germany) digestion step to eliminate
genomic DNA. RNA was eluted in two steps using pre-heated RNA-free water and the concen-
tration was checked using a Nano-drop ND-1000 spectrophotometer (Thermo Scientific, Wil-
mington, USA). Equal amounts of total RNA (0.1–1.5 μg) were reversed transcribed using the
High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Lithuania) according to
the manufacturer’s protocol. The cDNA was subsequently used to determine the mRNA levels
of Trpm6, Trpm7, Slc41a1, Slc41a2, Slc41a3, Cnnm1, Cnnm2, Cnnm3, Cnnm4, Gck and Abcc8
in islets and Trpm7, Cacna1c, Cacna1d, Ins1, Kcnj11, Abcc8, and Gck in INS-1 cells using com-
mercially available Taqman probes by the StepOnePlus Real-Time PCR System (Applied Bio-
systems) and normalized to Actb expression (Table 1). Data were analyzed using the Livak (2-
ΔΔCT) method.
INS-1 cells
Culture. INS-1 832–13 cells were cultured in RPMI 1640 GlutaMaxTM (Gibco, Darmstadt,
Germany) supplemented with 10% FBS, 50 μM β-mercaptoethanol (Sigma, St. Louis, USA), 1
mM sodium pyruvate (Sigma, St. Louis, USA), 1% HEPES (Gibco, Paisley, Scotland), and 1%
pen/strep in a humidified atmosphere (37˚C, 5% CO2). For mRNA expression analysis, INS-1
cells were seeded in 12-well plates (3 x 105 cells per well) to reach confluence in 72 hrs. For the
last 48 hrs, INS-1 cells were transfected with siTrpm7 (siGENOME SMARTpool siRNA, Dhar-
macon, Lafayette, USA) (final concentration 20 nM) and Lipofectamine1 RNAiMAX reagent
(Invitrogen, Carlsbad, USA) (1 ng/ml) in Opti-MEM (Gibco, Paisley, Scotland).
INS-1 static insulin secretion. INS-1 cells were cultured in 24-well plates (3 x 105 cells
per well) prior to the static secretion assay. INS-1 cells were washed in HBSS buffer (in mM:
114 NaCl, 4.7 KCl, 25.5 NaHCO3, 1.2 KH2PO4, 1.16 MgCl2, 20 HEPES, 2.5 CaCl2 (pH 7.4 with
NaOH)), supplemented with 0.07% BSA. After pre-incubation for 2 hrs in HBSS without D-
glucose (non-stimulant condition), INS-1 cells were challenged for 0.5 hr with final concentra-
tions of D-glucose and MgCl2, as indicated. At the end of the incubation period, both the
supernatant and the total insulin content (obtained by lysing cells in RIPA buffer) were col-
lected, centrifuged for 5 min, at 14,000 rpm, 4˚C, and directly stored at -20˚C. Insulin secre-
tion and total insulin content were determined using a mouse insulin ELISA kit.
Statistics. In all experiments, all data are expressed as the mean ± SEM. All statistical anal-
yses were performed using GraphPad (Prism 7) software. Statistical comparisons were
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analyzed by an unpaired Student’s t-test or by a two-way ANOVA with a Tukey’s multiple
comparison test. p< 0.05 was regarded as statistically significant.
Results
Acute lowering of Mg2+ does not affect insulin secretion in pancreatic β
cells under normal- and hyperglycemic conditions
To investigate whether Mg2+ fulfils a functional role in pancreatic β cells in a normal and
hyperglycemic environment, acute effects of extracellular Mg2+ on insulin secretion were
examined in primary mouse islets of Langerhans (Fig 1). Insulin secretion at normal (1.0
mM) extracellular Mg2+ for 1hr increased 6-fold in response to elevation of glucose from 2
to 20 mM (Fig 1A) and increased 3-fold when expressed as a percentage of insulin content
(Fig 1B). Reduction of extracellular Mg2+ from 1.0 to 0.5 mM for 1 hr had no effect on either
basal insulin secretion or that stimulated by 20 mM glucose (Fig 1A and 1B). We next
assessed the effects of low Mg2+ in combination with hyperglycemia. Culture at 25 mM glu-
cose (1.2 mM Mg2+) for 24 hrs enhanced basal insulin secretion but was without effect on
GSIS. Subsequent exposure to 0.5 or 1.0 mM Mg2+ for 1 hr did not alter basal insulin secre-
tion or GSIS (Fig 1C and 1D). Likewise, increasing the time of culture to 48 hrs at normal
(11 mM) or high (25 mM) glucose before acutely lowering extracellular Mg2+ did not alter
the results (S1 Fig). Thus, acute exposure to low extracellular Mg2+ does not affect insulin
secretion.
Table 1. Taqman gene expression assays used for RT-PCR analyses.
Target Gene Taqman Gene Expression Assays
Primary mouse islets of Langerhans
Actb Mm00607939_s1
Trpm6 Mm00463112_m1
Trpm7 Mm00457998_m1
Slc41a1 Mm00715604_m1
Slc41a2 Mm01250930_m1
Slc41a3 Mm01182529_m1
Cnnm1 Mm00518996_m1
Cnnm2 Mm01205090_m1
Cnnm3 Mm01227346_m1
Cnnm4 Mm01227316_m1
Gck Rn00561265_m1
Abcc8 Rn01476317_m1
INS-1 cells
Trpm7 Rn01328216_m1
Kcnj11 Rn01764077_s1
Abcc8 Rn01476317_m1
Cacna1c Rn00709287_m1
Cacna1d Rn01453395_m1
Ins1 Rn02121433_g1
Gck Rn00561265_m1
All Taqman Assays used for experiments in primary mouse islets of Langerhans (top) and INS1 cells (bottom) were
commercially available (Applied Biosystems). Actb was used as control in all RT-PCRs.
https://doi.org/10.1371/journal.pone.0217925.t001
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Effects of prolonged exposure to low extracellular Mg2+ on insulin
secretion
To determine whether prolonged exposure to low extracellular Mg2+ affects GSIS, primary
mouse islets of Langerhans were cultured for 24 hrs at either low (0.1 mM) or physiological
(1.0 mM) extracellular Mg2+ and under both normal (11 mM) or hyperglycemic (25 mM) glu-
cose concentrations. Insulin secretion was then measured in response to 2 and 20 mM glucose
(Fig 2A–2D). In islets cultured at 11 mM glucose, elevation of glucose from 2 to 20 mM
increased insulin secretion significantly at both low and normal Mg2+ (16-fold and 30-fold,
respectively; Fig 2A and 2B). In islets cultured at 25 mM glucose, there was no difference in
basal insulin secretion (2mM glucose) at low and normal Mg2+ (Fig 2C and 2D). However,
insulin secretion at 20 mM glucose was significantly higher in islets exposed to 0.1 mM Mg2+
compared to 1.0 mM Mg2+ (Fig 2C and 2D). Thus, in islets cultured under hyperglycemic, low
Mg2+ conditions, insulin secretion in response to 20 mM glucose is potentiated.
Fig 1. Acute lowering of Mg2+ does not affect insulin secretion in pancreatic β cells under normal- and hyperglycemic conditions. (A-B)
Insulin secretion from isolated islets (n = 10 replicates, islets from 16 mice, 8 islets per replicate) challenged by 2 mM and 20 mM glucose at 0.5
mM Mg2+ (solid bar) and 1.0 mM Mg2+ (open bar) for 1 hr, after 24 hrs of culture at 11 mM glucose (1.2 mM Mg2+). (C-D) Insulin secretion
from mouse pancreatic islets (n = 3, islets from 3 mice, 8 islets per replicate) stimulated by 2 mM and 20 mM glucose with 0.5 mM Mg2+ (solid
bar) and 1.0 mM Mg2+ (open bar) for 1 hr after 24 hrs of culture at 25 mM glucose (1.2 mM Mg2+). Insulin secretion is presented as ng/islet/hr
(A, C) and as normalized to total insulin content (B, D). Statistical significance was determined by two-way ANOVA. �, p< 0.05, 20 mM
glucose vs. 2 mM glucose.
https://doi.org/10.1371/journal.pone.0217925.g001
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Fig 2. Effects of prolonged exposure to low extracellular Mg2+ on insulin secretion and gene expression. (A-B) Insulin secretion from isolated islets
(n = 5 replicates, islets from 4 mice, 8 islets per replicate) challenged by 2 mM and 20 mM glucose at 0.1 mM Mg2+ (solid bar) and 1.0 mM Mg2+ (open bar)
for 1 hr, after 24 hrs of culture at 11 mM glucose and either 0.1 mM or physiological (1.0 mM) extracellular Mg2+. (C-D) Insulin secretion from mouse
pancreatic islets (n = 5 replicates, islets from 4 mice, 8 islets per replicate) stimulated by 2 mM and 20 mM glucose at 0.1 mM Mg2+ (solid bar) and 1.0 mM
Mg2+ (open bar) for 1 hr after 24 hrs of culture at 25 mM glucose, and either 0.1 mM or 1.0 mM extracellular Mg2+. Insulin secretion is presented as ng/islet/
hr (A, C) and as normalized to total insulin content (B, D). �, p< 0.05 (2 mM vs. 20 mM glucose); #, p< 0.05 (0.1 mM Mg2+, 20 mM glucose vs. 1.0 mM
Mg2+, 20 mM glucose). Two-way ANOVA with a Tukey’s multiple comparison test. (E-L) The mRNA transcript levels of Gck (E), Abcc8 (F), Trpm6 (G),
Low extracellular magnesium does not impair glucose-stimulated insulin secretion
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Extracellular Mg2+ does not regulate mRNA levels of selected genes
The mRNA expression levels of selected genes were examined by RT-qPCR in islets cultured
at 11 mM or 25 mM glucose and either 0.1 mM or 1.0 mM Mg2+. There were no significant
effects on mRNA transcript levels of key Mg2+ channels and exchangers; Trpm6, Trpm7,
Slc41a1, Slc41a3, Cnnm2, and Cnnm4 (Fig 2G–2L). There were also no significant differences
in mRNA expression levels of Gck and Abcc8 between low Mg2+ and physiological Mg2+ con-
centrations and between normal and hyperglycemic glucose conditions (Fig 2E and 2F).
Extracellular Mg2+ does not affect GSIS in INS-1 cells
To verify our results from the experiments on primary mouse islets, we assessed the effects of
low Mg2+ on GSIS in the rat insulinoma INS-1 cell line (Fig 3). Acute reduction of extracellular
Mg2+ from 1.0 to 0.5 mM for 0.5 hr had no effect on either basal insulin secretion or that stim-
ulated by 20 mM glucose (Fig 3A and 3B). Additionally, prolonged culture of 48 hrs under low
Mg2+ conditions did not affect the transcript levels of Gck, Kcnj11, Abcc8, Cacna1c, and Cac-
na1d nor Trpm7 and Slc41a1 (Fig 3C–3I).
Trpm7 is the main Mg2+ channel in primary mouse islets
To understand which Mg2+ channels and transporters/exchangers play a pivotal role in pan-
creatic β cells, their mRNA expression levels were analyzed in primary mouse islets of Langer-
hans using RT-qPCR (Fig 4). RT-qPCR analysis demonstrated that the Mg2+ channel Trpm7
and the Mg2+ exchanger Cnnm4 were the highest expressed among those tested in primary
mouse islets. Notably, Trpm7 expression was 8-fold higher than its close homologue Trpm6,
both of which are crucial for epithelial Mg2+ transport (Fig 4A).
Knockdown of Trpm7 results in increased insulin secretion in INS-1 cells
Given the high expression levels of the Mg2+ channel Trpm7, we hypothesized that knockdown
of Trpm7 might reduce intracellular Mg2+ levels and thereby influence GSIS. Trpm7 was
knocked down using siRNA in INS-1 cells (Fig 5). Trpm7 expression was 60% reduced by
siRNA transfection (S2 Fig). Basal insulin secretion in Trpm7 knockdown cells was similar to
that in control cells. Secretion was significantly increased (by 16-fold) in response to 20 mM
glucose in Trpm7 knockdown cells (p = 0.006). At 20 mM glucose, there was significantly
more secretion in Trpm7 knockdown cells than control cells (Fig 5A and 5B). Trpm7 knock-
down did not affect the mRNA expression levels of key players in GSIS including Gck, Ins1,
Kcnj11, Abcc8, Cacna1c, and Cacna1d (Fig 5C–5H).
Discussion
This study demonstrates that reduced extracellular Mg2+ does not impair insulin secretion
from pancreatic β-cells. This conclusion is based on the following results: i) Acute exposure to
low extracellular Mg2+ has no effect on insulin secretion from either isolated mouse islets of
Langerhans or INS-1 cells; ii) In islets cultured at 25 mM glucose, to mimic the hyperglycemic
state found in T2DM, insulin secretion was actually enhanced by reducing extracellular Mg2+;
iii) The mRNA expression levels of Mg2+ channels/transporters and key players in GSIS, in
both islets and INS1 cells, were unaffected by extracellular Mg2+.
Trpm7 (H), Slc41a1 (I), Slc41a3 (J), Cnnm2 (K), Cnnm4 (L) were measured in islets (n = 3 replicates, islets from 15 mice, 8 islets per replicate) after 24 hrs of
culture at 11 mM glucose (solid bar), or 25 mM glucose (open bar) and either 0.1 mM Mg2+ or 1.0 mM Mg2+. mRNA expression levels were determined by
quantitative RT-qPCR and normalized to Actb expression. Data are expressed relative to 1.0 mM Mg2+, 11 mM glucose.
https://doi.org/10.1371/journal.pone.0217925.g002
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Previous experimental approaches have focused on the long-term effects of Mg2+ on insulin
secretion in mouse and rat models. The results are conflicting. Reis et al showed a higher insulin
response to basal and 8.3 mmol/L glucose concentrations in isolated islets of rats fed a Mg2+-defi-
cient diet for 11 weeks [11]. In contrast, Legrand et al. observed a reduced insulin release [12].
The difficulty with long term Mg
2+
deprivation is that both the extracellular and intracellular
Fig 3. Extracellular Mg2+ does also not affect GSIS in INS-1 cells. (A-B) INS1 cells were cultured for 48 hrs at 11 mM glucose (1.2 mM Mg2+) followed by 24
hrs at 5 mM glucose (1.2 mM Mg2+) prior to the experiment. Insulin secretion from INS-1 cells stimulated by 2 mM and 20 mM glucose with 0.5 mM Mg2+
(solid bar) and 1.0 mM Mg2+ (open bar) for 0.5 hr (representative experiment from three independent experiments). Insulin secretion is presented as ng/3�105
cells per hr (A) and normalized to total cell content (B). �, p< 0.05 (2mM vs. 20mM glucose) using two-way ANOVA. (C-I) The mRNA transcript levels of Gck
(C), Kcnj11 (D), Abcc8 (E), Cacna1c (F), Cacna1d (G), Trpm7 (H), and Slc41a1 (I) were measured from INS-1 cells after 72 hrs of culture at standard glucose
(11 mM) of which the last 48 hrs in low Mg2+ (0.1 mM) (solid bar) or physiological Mg2+ (1.0 mM) (open bar) culture conditions. mRNA expression levels
were determined by quantitative RT-qPCR and normalized for Actb expression. Data are expressed relative to 1.0 mM Mg2+.
https://doi.org/10.1371/journal.pone.0217925.g003
Low extracellular magnesium does not impair glucose-stimulated insulin secretion
PLOS ONE | https://doi.org/10.1371/journal.pone.0217925 June 4, 2019 8 / 13
Mg2+ concentration may be reduced. In our approach, we aimed to separate the effects of extra-
cellular Mg2+ and the effects of intracellular Mg2+. Interestingly, an acute reduction of extracellu-
lar Mg2+ did not affect insulin secretion in either primary islets or INS-1 cells. Similar findings
were reported by an early study in perfused rat pancreas [15]. In contrast, knockdown of Trpm7,
which is permeable to Mg2+, significantly increased glucose-stimulated insulin release. This leads
us speculate that changes in intracellular Mg2+ might modulate insulin release. Indeed, data
from RIN m5F cells showed a stimulatory effect on insulin secretion when intracellular Mg2+
levels were reduced [16, 17].
Our results indicate that transient hypomagnesemia does not affect insulin secretion. How-
ever, patients with hypomagnesemia have chronic hypomagnesemia. Long term hypomagne-
semia might reduce intracellular Mg2+ levels and thereby modify GSIS. Indeed, our results
show that culturing islets for 24 hrs in a hyperglycemic environment under low Mg2+ condi-
tions stimulated GSIS. This is in line with the negative correlation between magnesium levels
and HOMA-B in a Canadian T2DM cohort [9].
Interestingly, our data show the importance of Trpm7 in insulin secretion from pancreatic
islets. Trpm7 is the highest expressed Mg2+ channel. Although a major limitation of our study
is the lack of measurement of intracellular Mg2+ levels, others have extensively reported that
targeting Trpm7 severely reduces intracellular Mg2+ levels [18–20]. Additionally, as TRPM7
can also function as a Ca2+ channel, we cannot exclude that TRPM7-mediated Ca2+ uptake
explains the increased insulin secretion [21].
In recent years, several studies have shown that hypomagnesemia is a risk factor for pro-
gression of T2DM [3, 22]. Several hypotheses that could explain the mechanisms of this associ-
ation have been proposed [23, 24]. Given the conflicting literature and our data showing that
acute changes in extracellular Mg2+ do not inhibit insulin secretion in both pancreatic islets
and INS-1 cells, we postulate that hypomagnesemia does not exert its effect primarily on insu-
lin secretion. Based on recent large studies in animals and patients, other factors such as lipid
Fig 4. Trpm7 is the main Mg2+ channel in primary mouse islets. (A) The mRNA transcript levels of Trpm7, Trpm6,
Slc41a1, Slc41a2, Slc41a3, Cnnm1, Cnnm2, Cnnm3, and Cnnm4 in islets (n = 6 replicates, islets from 6 mice). mRNA
expression levels were determined by quantitative RT-qPCR and normalized to Actb expression. Data are expressed
relative to Trpm7 expression.
https://doi.org/10.1371/journal.pone.0217925.g004
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metabolism may be more important in determining the interaction between hypomagnesemia
and progression of type 2 diabetes [4, 25, 26].
Fig 5. Knockdown of Trpm7 results in increased insulin secretion in INS-1 cells. (A-B) Insulin secretion from INS-1 cells (n = 3 experiments, 3 replicates
each) stimulated by 2 mM and 20 mM glucose (1.0 mM Mg2+). Cells were cultured for 24 hrs at 11 mM glucose (1.2 mM Mg2+) followed by a further 48 hrs
culture at 11 mM glucose (1.2 mM Mg2+) after transfection with siNON-targeting (siNT) (solid bar) or siTrpm7 (open bar). Insulin secretion is presented as
ng/3�105 cells per hour (A) and normalized to total cell content (B). �, p< 0.05 (2 mM vs. 20 mM glucose); #, p< 0.05 (siTrpm7, 20 mM glucose vs. siNT, 20
mM glucose). Two-way ANOVA. (C-H) The mRNA transcript levels of Gck (C), Ins1 (p = 0.069) (D), Kcnj11 (p = 0.069) (E), Abcc8 (p = 0.058) (F), Cacna1c
(G), Cacna1d (H) measured in INS-1 cells after 24 hrs of culture at 11 mM glucose (1.2 mM Mg2+) followed by a further 48 hrs culture at 11 mM glucose (1.2
mM Mg2+) after transfection with siNON-targeting (siNT) (solid bar) or siTrpm7 (open bar) (n = 3 experiments, 3 replicates each). mRNA expression levels
were determined by quantitative RT-qPCR and normalized to Actb expression. Data are expressed relative to siNT levels.
https://doi.org/10.1371/journal.pone.0217925.g005
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In conclusion, we showed in different models that changes in extracellular Mg2+ do not
impair glucose-stimulated insulin secretion. However, further research is needed to elucidate
whether regulation of the intracellular Mg2+ concentration by Trpm7 may influence insulin
release.
Supporting information
S1 Table. Home-made RPMI medium.
(DOCX)
S1 Fig. GSIS following culture of isolated islets for 48 hrs. (A-B) Insulin secretion from iso-
lated islets (n = 3 replicates, 9 mice, 8 islets per replicate) challenged with 2 mM and 20 mM
glucose and 0.5 mM Mg2+ (solid bar) or 1.0 mM Mg2+ (open bar) for 1 hr after 48 hrs of cul-
ture at 11 mM glucose (1.2 mM Mg2+). (C-D) Insulin secretion from mouse pancreatic islets
(n = 3 replicates, 9 mice, 8 islets per replicate) stimulated by 2 mM and 20 mM glucose with
0.5 mM Mg2+ (solid bar) and 1.0 mM Mg2+ (open bar) for 1 hr after 48 hrs of culture at 25
mM glucose (1.2 mM Mg2+). Insulin secretion is presented as ng/islet/hr (A, C) and normal-
ized to total insulin content (B, D). �, p< 0.05 (2 mM vs. 20 mM glucose); Two-way ANOVA.
(DOCX)
S2 Fig. Confirmation of Trpm7 knockdown in INS-1 cells. (A) RT-qPCR of Trpm7 mRNA
in INS-1 cells (n = 3 experiments, 3 replicates each) following transfection with siNON-target-
ing (siNT) (solid bar) or siTrpm7 (open bar). mRNA expression levels were determined by
quantitative RT-qPCR and normalized to Actb expression. Data are expressed relative to siNT.
�, p< 0.05, Student’s t-test (two-tailed).
(DOCX)
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